Targeting respiratory syncytial virus vaccination using individual prediction.

Competing Interests: LJB has regular interaction with pharmaceutical and other industrial partners but has not received personal fees or other personal benefits, and is the founding chairman of the ReSViNET Foundation. JGW has been an investigator for clinical trials sponsored by pharmaceutical companies including AstraZeneca, Merck, Pfizer, Sanofi, and Janssen with all funds paid to University Medical Center Utrecht, and has participated in the advisory boards of Janssen and Sanofi with fees paid to UMCU.